In Vitro Activity of Ceftolozane-Tazobactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates Obtained from Across Canada as Part of the CANWARD Study, 2008–2016

BACKGROUND: Ceftolozane-tazobactam (C/T) is a novel β-lactam β-lactamase inhibitor combination with a broad spectrum of activity that includes Pseudomonas aeruginosa. The purpose of this study was to evaluate the in vitro activity of C/T and relevant comparators vs. a large collection of antimicrobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Walkty, Andrew, Adam, Heather J, Baxter, Melanie, Lagace-Wiens, Philippe, Karlowsky, James, Hoban, Daryl, Zhanel, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630865/
http://dx.doi.org/10.1093/ofid/ofx163.913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630865/
http://dx.doi.org/10.1093/ofid/ofx163.913

Ejemplares similares